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Abstract
The use of high-fidelity computational simulations promises to enable high-throughput
hypothesis testing and optimisation of cancer therapies. However, increasing realism
comes at the cost of increasing computational requirements. This article explores the
use of surrogate-assisted evolutionary algorithms to optimise the targeted delivery of a
therapeutic compound to cancerous tumour cells with the multicellular simulator, Physi-
Cell. The use of both Gaussian process models and multi-layer perceptron neural network
surrogate models are investigated. We find that evolutionary algorithms are able to ef-
fectively explore the parameter space of biophysical properties within the agent-based
simulations, minimising the resulting number of cancerous cells after a period of sim-
ulated treatment. Both model-assisted algorithms are found to outperform a standard
evolutionary algorithm, demonstrating their ability to perform a more effective search
within the very small evaluation budget. This represents the first use of efficient evolu-
tionary algorithms within a high-throughput multicellular computing approach to find
therapeutic design optima that maximise tumour regression.
Keywords: Agent-based model, evolutionary algorithm, cancer, PhysiCell,
high-throughput computing, surrogate modelling
1. Introduction
PhysiCell (Ghaffarizadeh et al., 2018) is an open source1 multicellular simulator based
on the biotransport solver, BioFVM (Ghaffarizadeh et al., 2016). BioFVM simulates
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substrate secretion, diffusion, uptake, and decay; while PhysiCell models the emergent
tissue-scale behaviour by simulating cell cycling, death, volume, mechanics, and motility.
PhysiCell enables the simulation of new environmental substrates, cell types, and systems
of cells, providing a general-purpose toolkit for exploring multicellular systems.
Norton et al. (2019) present a review of agent-based models used to study cancer-
immune interaction and immunotherapy; and Metzcar et al. (2019) provide a more gen-
eral overview of cell-based computational modelling in cancer biology. Many proposed
cancer therapies attempt to target malignant cells by finding specific surfaces or molecules
in order that drugs can be conjugated to custom antibodies or encapsulated in custom
nanoparticles. Ghaffarizadeh et al. (2018) introduced the agent-based PhysiCell 2-D
anti-cancer biorobots simulation. This began the design of cell-cell interaction rules to
create a multicellular cargo delivery system that actively delivers a cancer therapeutic
beyond regular drug transport limits to hypoxic cancer regions. These model rules were
manually tuned to achieve this (as yet unoptimised) design objective, requiring weeks of
people-hours to configure, code, test, visualise, and evaluate (Ozik et al., 2018).
Ghaffarizadeh et al. (2018) also presented 3-D simulations of cancer immunotherapy.
Using this simulator, Ozik et al. (2018) performed a human-selected parameter sweep (27
parameter sets; each set sampled 10 times) with each simulation requiring ≈ 2 days to
complete. The results provided insights into therapeutic failure, thus demonstrating the
potential of high-throughput computing to investigate high dimensional cancer simulator
parameter spaces. High-throughput model investigation and hypothesis testing provides
a new paradigm for solving complex problems, gaining new insights, and improving cancer
treatment strategies (Ozik et al., 2018).
Surrogate model-based optimisation has long been used in applications requiring ex-
pensive parameter evaluations, whether via simulated or physical testing (Sacks et al.,
1989; Jones et al., 1998; Settles, 2010). In this article, we explore the use of surrogate-
assisted evolutionary algorithms (EAs) to sequentially optimise the targeted delivery of a
therapeutic compound to cancerous tumour cells with the multicellular simulator, Physi-
Cell. This represents the first use of efficient EAs within a high-throughput multicellular
computing approach to find therapeutic design optima that maximise tumour regression.
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2. Background
The use of surrogate models to reduce the number of costly EA fitness evaluations
can be traced back to the origins of the discipline (Dunham et al., 1963). Jin et al. (2018)
present an overview of the process: first the variables to optimise are chosen; some initial
parameters are then evaluated; a surrogate (regression) model is selected and used to
build a model of the evaluated parameters; followed by a search of the model to identify
new parameter values to evaluate; and the newly evaluated parameters added to the
existing data. The process loops via continued iterations of model building, searching,
and evaluation of selected parameters.
Many regression models have been used as a surrogate for the real fitness function, in-
cluding multi-layer perceptron (MLP) based artificial neural networks (e.g., Bull, 1997),
Gaussian processes (GP; also known as Kriging; e.g., Liu et al., 2014), radial basis func-
tions (RBF; e.g., Regis, 2014), support vector regression (e.g., Yun et al., 2009), particle
swarm optimisation (e.g., Wang et al., 2017), Markov networks (e.g., Brownlee et al.,
2013), and coevolved fitness predictors (Schmidt and Lipson, 2008). Many ensembles
have also been explored (e.g., Wang et al., 2018). Probabilistic models such as GP are
perhaps the most widely used surrogate since they provide a measure of confidence that
can be used to efficiently select samples for evaluation (Jin et al., 2018). Preen and Bull
(2016) showed that with very small and noisy samples there is little difference between
the modelling approaches, with MLPs appearing to be a robust approach capable of
capturing the underlying structure of the search space.
The computational complexity of model building relative to the sampling expense is a
key consideration, particularly in the case where large archive sets are used for training;
for example, the computation time for GP training increases in cubic with the number
of training data (Shahriari et al., 2016). MLP models are typically adopted when there
are a large number of decision variables and/or training data (Chugh et al., 2017). This
leads to a further key consideration, which is whether to use the full archive set for
model training. It may be necessary to restrict the number of samples for use with a
computationally complex model such as GP when there is a large archive set (Jin et al.,
2018). Additionally, if there are any significant temporal affects, issues surround how
best to select the subset for training (Preen and Bull, 2017).
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The task of selecting which samples to evaluate is analogous with the problem of
active learning wherein the algorithm is able to interactively query an oracle (e.g., a
user) to obtain the output at a given data point (Settles, 2010). For online data-driven
optimisation, initial data collection is often simply performed via random selection or
a design of experiments technique such as Latin hypercube sampling (Jin et al., 2018).
Subsequent samples are selected through the use of an acquisition function (also known
as the infill sampling criteria) which rates the expected utility of evaluating a candidate
solution (Shahriari et al., 2016). The most commonly used acquisition functions are
the mean of model prediction, and the expected improvement (EI; Jiao et al., 2019).
Acquisition functions typically aggregate the model predicted fitness (e.g., mean) and
estimated confidence (e.g., standard deviation) to explore regions of both high promise
and high uncertainty. In addition to variance-based sampling, query-by-committee, cross-
validation, and gradient-based methods also exist (Liu et al., 2018).
The use of the acquisition function is performed within an overall model management.
Jin (2011) categorised approaches to model management as generational, individual, or
population-based, depending upon whether whole generations, samples of individuals
within a generation, or sub-populations are evaluated. The pre-selection approach (Em-
merich et al., 2002) uses the model to rate M number of offspring and the best of these
are chosen for evaluation on the real fitness function. As highlighted by Jin (2011),
the main difference between individual-based strategies and pre-selection is that the real
fitness value is always used for selection, whereas in individual-based methods selection
may be based on fitness values from the surrogate. This potentially makes the approach
more robust to noise. Pre-selection has previously been shown effective for the evolution
of (noisy) physical systems in which each design is physically instantiated and evaluated
for fitness (Preen and Bull, 2015, 2016, 2017).
Four main categories of uncertainty (or noise) are frequently encountered in real-world
optimisation problems (Jin and Branke, 2005):
1. Uncertainty in the objective function evaluation. This is common in stochastic
simulations and physical systems where evaluations with the same parameters pro-
duce different results, e.g., by sensory measurement errors. Efficiently reducing the
objective function error requires optimally selecting how many samples to perform
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for a given parameter set. Issues such as how best to aggregate the results, e.g., by
mean or median may also affect convergence.
2. The objective function is approximated by a surrogate model. Efficiently reducing
the model error requires optimally selecting which samples to evaluate with the
real objective function to provide new training data and avoidance of over-fitting
through validation (Bischl et al., 2012). Approximated objective values are also
encountered where the function evaluations take place over time and partial fitness
scores can be observed by early termination (Park et al., 2013). Approximation er-
ror can be beneficial to the search process by aiding the escape of local optima (Lim
et al., 2010).
3. Dynamic optimisation wherein the objectives change over time (e.g., Chen et al.,
2018). In these scenarios, population diversity and memory mechanisms are essen-
tial.
4. Robust optimisation (e.g., Yu and Suprayitno, 2017) which seeks solutions that are
less sensitive to small parameter perturbations, e.g., due to manufacturing toler-
ances. This typically involves a trade-off between solution quality and robustness.
Rakshit et al. (2017) present an overview on techniques for dealing with noisy evo-
lutionary optimisation. Uncertainty in the objective function can be addressed via the
explicit averaging of resampled parameters or implicit averaging using a large population
size. The evolutionary selection mechanism may also be modified to account for noisy
evaluations; for example, by only accepting offspring with observed fitness greater than
the parent’s plus some threshold. Repeated sampling is typically more effective for noise
handling than parent populations and threshold selection, resulting in an exponential
speed-up for noisy evolutionary optimisation in some cases (Qian et al., 2018). The
number of samples to perform for a given parameter set can either remain fixed (static)
for all candidate solutions or be dynamically allocated to each, e.g., based on the sample
variance (Siegmund et al., 2013).
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3. Physics-based Multicellular Simulations
3.1. Methodology
Here we use the PhysiCell 2-D anti-cancer biorobots simulator (Ghaffarizadeh et al.,
2018). This performs a multicellular simulation of targeted drug delivery by modelling
three types of cells:
 Oxygen consuming cancer cells that generate a chemoattractant c1 forming an
oxygen gradient which can be used to guide worker cells.
 Worker cells that may adhere to cargo cells. Each cell has a persistence time,
migration speed, migration direction, and migration bias. Worker cells perform a
biased random migration towards cancer cells when adhered to cargo, and a biased
random migration towards cargo cells when unadhered. Migration biases range [0,1]
with 0 representing Brownian motion and 1 deterministic motion. The motility of
unadhered worker cells is disabled if c1 falls below a threshold.
 Cargo cells that secrete a diffusible chemoattractant c2 used to guide worker cells.
Adhered cargo cells detach from worker cells and secrete a therapeutic compound
that induces apoptosis in nearby tumour cells when oxygenation falls below the
cargo release o2 threshold.
Each simulation is initialised with a 200 micron radius tumour. After 7 simulated
days of tumour growth, 500 cells are “injected” near the tumour: 10% worker cells and
90% cargo cells. The simulation subsequently continues for 3 additional days of cancer
therapy. A single simulation requires ≈ 5 minutes of wall-clock time on an Intel® Xeon®
CPU E5-2650 v4 @ 2.20GHz with 64GB RAM using half of the 48 cores. Here we search
the N = 6 parameters specifying worker agent characteristics and cargo properties with
the goal of minimising the resulting number of cancer cells after a period of simulated
treatment. All other parameters remain at their original values as shown in Table 1.
In particular, we explore the attached worker migration bias [0,1]; the unattached
worker migration bias [0,1]; worker relative adhesion [0,10]; worker relative repulsion
[0,10]; worker motility persistence time (minutes) [0,10]; and the cargo release o2 thresh-
old (mmHg) [0,20]. We adopt the surrogate-assisted pre-selection approach (and pa-
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Table 1: Default multicellular simulation parameters.
Maximum attachment distance 18 microns
Minimum attachment distance 14 microns
Worker apoptosis rate 0 minutes−1
Worker migration speed 2 microns/minute
Worker o2 relative uptake 0.1 minutes
−1
Cargo o2 relative uptake 0.1 minutes
−1
Cargo apoptosis rate 4.065e-5 minutes−1
Cargo relative adhesion 0
Cargo relative repulsion 5
Damage rate 0.03333 minutes−1
Repair rate 0.004167 minutes−1
Drug death rate 0.004167 minutes−1
Maximum relative cell adhesion distance 1.25
Elastic coefficient 0.05 minutes−1
Maximum elastic displacement 50 microns
Motility shutdown detection threshold 0.001
Attachment receptor threshold 0.1
rameter values) previously used successfully to perform physical test-driven optimisa-
tion (Preen and Bull, 2017). As benchmark, a steady-state genetic algorithm (GA) with
population size P = 20 is used; tournament size T = 3 for both selection and replacement;
uniform crossover is performed with X = 80% probability; and a per allele mutation rate
µ = 1/N with a uniform random step size s = [−5, 5]%. A static sampling approach is
used wherein k simulation runs are performed for each candidate solution before assign-
ing the fitness as the mean number of remaining cells after 7 simulated days of tumour
growth plus 3 days of targeted drug delivery.
For the surrogate-assisted GA, all individuals in the initial population are evaluated
and a regression model fit. Subsequently, evolution proceeds by iteratively selecting 2
parents via tournament and then creating and evaluating M = 1000 offspring with the
model via an acquisition function. The most promising of these is then selected for
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evaluation by the multicellular simulator and replaces an individual in the population
selected via a negative tournament. Finally, the evaluated archive set is updated and
the model retrained. The full archive set is used for training since there are no temporal
affects on sampling, the time required to fit the model is insignificant in comparison with
the sample evaluation time, and only a few decision variables are optimised. Algorithm 1
provides an outline of the surrogate-assisted GA with static sampling.
Since MLPs are extrapolative and GPs are interpolative, here we employ both ap-
proaches to model building and observe their effects on the evolved biophysical parame-
ters. Here, the GP model (Rasmussen and Williams, 2006) uses an RBF kernel function
and the MLP uses H = 10 rectified linear units in the hidden layer. Both models are
trained using the limited-memory Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) quasi-
Newton optimisation algorithm (Byrd et al., 1995). As the GP model provides a measure
of confidence (i.e., standard deviation) for each prediction, the EI is used as the acquisi-
tion (rating) function to select the next offspring; whereas the MLP does not provide a
measure of confidence and so the best predicted fitness is used in this case. Algorithm 2
shows the EI rating function used for the GP model. For the MLP model, Rating() in
Algorithm 1 returns the model predicted fitness. All experiments are initialised with the
same randomly generated population.
3.2. Results
Since each simulation run is costly, we initially explored the case with k = 1. However,
after 400 evaluations/simulations, the performance of the fittest individual discovered by
the GA was not significantly different than the fittest individual in the initial population,
p > 0.05 using a Wilcoxon rank-sums test, showing that the GA is severely misled by
the significant variance in simulation runs with the same parameter set.
Figure 1 shows the mean number of cells resulting from the fittest individual discov-
ered for each algorithm with k = 10. After evaluating 200 candidates (2000 simulations),
the best GP-assisted solution (mean = 852.10, SD = 40.43, samples = 10, min = 773,
median = 870, kurtosis = -0.89) and the best MLP-assisted solution (mean = 852.20, SD
= 39.84, samples = 10, min = 791, median = 853, kurtosis = -0.74) are significantly less
than the best GA solution without surrogate assistance (mean = 889.30, SD = 32.75,
samples = 10, min = 831, median = 898, kurtosis = -0.83), p ≤ 0.05 using a Wilcoxon
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rank-sums test. There is no significant difference between the surrogate models. All
algorithms found solutions with a significantly lower mean number of cells than the best
individual in the initial population (mean = 953.50, SD = 41.59, samples = 10, min =
887, median = 947, kurtosis = -1.10), p ≤ 0.05.
Figure 2 shows scatter plots of all evaluated individuals for each evolved parameter.
As can be seen, both surrogate-assisted EAs identified best solutions with a mean of 852
cells and these solutions have similar values for 4 of the parameters: ≈ 0.5 unattached
worker migration bias; ≈ 6 worker relative adhesion; ≈ 10 worker motility persistence
time; and ≈ 11 cargo release o2 threshold. However, the MLP-assisted model achieved
this with an attached worker migration bias of 0.89, whereas the GP-assisted solution
was 0.29. Additionally, the worker relative repulsion was 5.9, compared with 1.13 for the
GP-assisted model.
There appears to be a clear funnel with a minimum at ≈ 11 for the cargo release
o2 threshold, suggesting that this is the global optima for the parameter. Ghaffarizadeh
et al. (2018) used an initial cargo release o2 threshold of 10, finding that “once enough
cancer cells were killed, hypoxia was reduced so that worker cells clustered near the
oxygen minimum, but no longer released their cargo”. Increasing the threshold to 15
“reduced but did not eliminate this behaviour”. The results of these simulations suggest
that using a threshold of 11 results in the best performance. As Ghaffarizadeh et al.
(2018) note, “the cargo release rules need to be carefully engineered. Such a system
could potentially activate and deactivate to keep a tumour cell population in control,
and to reduce hypoxia [which is known to drive cancer cell adaptation to more aggressive
phenotypes (Wilson and Hay, 2011; Eales et al., 2016)]”.
An example run of the fittest evolved individual with the GP-surrogate model is shown
in Figure 3, showing that the worker cells appear to disperse evenly and effectively deliver
the cargo to the tumour.
4. Conclusions
This article has shown that EAs are able to effectively explore the parameter space
of biophysical properties within the agent-based multicellular simulator, PhysiCell. EAs
successfully minimised the number of cancerous cells after a period of simulated treat-
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ment. Both surrogate-assisted algorithms were found to outperform the standard GA,
thereby reducing the number of expensive simulations required. No significant difference
in the resulting number of cancerous cells was observed between the models, showing
the robustness of the overall pre-selection with static sampling approach employed. By
exploring both surrogate models that extrapolate and models that interpolate, we were
able to identify different parameter sets that achieved similar reductions in cancerous
cells. Thus, we have demonstrated the use of efficient EAs within a high-throughput
computing approach to find therapeutic design optima that maximise tumour regression.
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Algorithm 1: Surrogate-assisted GA with pre-selection and static sampling
1 N = 6, P = 20, k = 10, M = 1000, X = 0.8, µ = 1/N , s = 0.1, T = 3
2 Initialise population Pop = {~x1, . . . , ~xP } // ~x normalised [-1,1]
3 Evaluate Pop with the real objective function k times and add to archive A
4 while evaluation budget not exhausted do
/* build surrogate model */
5 Fit regression model R using A
/* pre-select offspring */
6 Parent p1 ← TournamentSelection(Pop, T )
7 Parent p2 ← TournamentSelection(Pop, T )
8 for M number of offspring do
9 Offspring a← p1
/* crossover */
10 if Random(0,1) < X then
11 Perform uniform crossover with a and p2
/* mutation */
12 for each parameter x in a do
13 if Random(0,1) < µ then
14 x← x+Random(−s, s)
/* evaluate offspring with surrogate model */
15 a.utility ← Rating(R, a,A)
/* select, evaluate, and add the most promising offspring */
16 Evaluate the best utility offspring with the real objective function k times
17 Add offspring to A
18 r ← NegativeTournamentSelection(Pop, T )
19 Replace r with offspring
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Algorithm 2: Expected improvement rating function
1 Input: fitted regression model R, candidate a, evaluated archive A
2 Output: model expected improvement of a
3 ei← 0
4 mean, std←R.predict(a)
5 if std != 0 then
6 imp← BestF itness(A)−mean // minimising
7 z ← imp/std
/* cdf() is the standard normal cumulative distribution function */
/* pdf() is the standard normal probability density function */
8 ei← imp× cdf(z) + std× pdf(z)
9 return ei
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Figure 1: Fittest individuals on the PhysiCell anti-cancer biorobots simulator. GA (triangle), GP-
assisted GA (circle), and MLP-assisted GA (square).
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Figure 2: Scatter plot of all evaluated individuals on the PhysiCell anti-cancer biorobots simulator.
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(a) Day 7 (b) Day 8
(c) Day 9 (d) Day 10
Figure 3: Example run of the fittest evolved individual with the GP-surrogate model on the PhysiCell
anti-cancer biorobots simulator after 200 candidate evaluations (2000 simulations.) Shown are the worker
cells (red), cargo cells (blue), and tumour cells (green) after 7 days of tumour growth and each subsequent
day of treatment. Attached worker migration bias = 0.29; unattached worker migration bias = 0.55;
worker relative adhesion = 6.24; worker relative repulsion = 1.13; worker motility persistence time =
9.26; cargo release o2 threshold = 10.94. Mean number of cells after 10 simulated days = 852.
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